Skip to main content
CDRE
NYSE Industrial Applications And Services

Cadre Holdings Discloses $34.5M CEO Expense Reimbursement, Significant Potential Dilution, and Board Changes

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Aerospace & Defense Stocks · Industrial
Sentiment info
Negative
Importance info
9
Price
$29.15
Mkt Cap
$1.242B
52W Low
$28.22
52W High
$48.76
52W Position info
3.3% above low
Off High info
40% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

CDRE is trading near its 52-week low of $28.22 (3.3% above the low).

Summary

Cadre Holdings' definitive proxy statement reveals over $34.5 million in 'unallocated expense reimbursement' for its CEO, significant potential dilution from equity plans, and material related-party transactions with a CEO-owned entity, alongside changes to its Board of Directors.


Key Events · Corporate Governance and Compliance · CDRE

  • CEO Received Over $34.5 Million in Expense Reimbursement

    CEO Warren B. Kanders' 2025 compensation included $34,531,948 for 'unallocated expense reimbursement,' a highly unusual and substantial amount.

  • Significant Potential Dilution from Equity Plans

    As of December 31, 2025, 9,683,220 shares remained available for future issuance under equity compensation plans, representing a potential dilution of approximately 22.6% of current outstanding shares.

  • Material Related-Party Transactions Disclosed

    The company paid $3 million to Kanders & Company, a firm solely owned by CEO Warren B. Kanders, for support related to two acquisitions in 2025 and 2026.

  • Board of Directors Changes Proposed

    Two current directors, Deborah A. DeCotis and Gianmaria C. Delzanno, are not nominated for re-election, while Mary Kissel and former director Nicholas Sokolow are proposed as new board members.


Analysis · CDRE · Industrial Applications And Services

This definitive proxy statement reveals several significant corporate governance and compensation issues that could negatively impact investor sentiment, especially with the stock trading near its 52-week low. The most striking disclosure is the over $34.5 million in 'unallocated expense reimbursement' for CEO Warren B. Kanders in 2025, which is an exceptionally large compensation component. Additionally, the company's equity compensation plans have a substantial 22.6% potential dilution from shares available for future issuance, which could weigh on shareholder value. Material related-party transactions totaling $3 million were paid to Kanders & Company, a firm solely owned by the CEO, for acquisition support. The proposed changes to the Board of Directors, with two current members not standing for re-election and two new/returning nominees, also represent a notable shift in governance. Investors should scrutinize these compensation practices, potential dilution, and related-party dealings.

How filings like this one have moved

In the 30 days to Nov 6, 2026, 51.2% of the 201 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.73%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CDRE was trading at $29.15 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $1.2B. The 52-week trading range was $28.22 to $48.76. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CDRE - Latest Insights

CDRE
Nov 04, 2026, 4:17 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $30.84
Real-time Price: $32.60 info
Change: +$1.76 (+6%) info
Market Cap: $1.396B info
CDRE
Nov 04, 2026, 4:15 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $30.84
Real-time Price: $32.60 info
Change: +$1.76 (+6%) info
Market Cap: $1.396B info
CDRE
Nov 04, 2026, 4:15 PM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $30.84
Real-time Price: $32.60 info
Change: +$1.76 (+6%) info
Market Cap: $1.396B info
CDRE
Aug 05, 2026, 4:28 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $32.00
Real-time Price: $32.60 info
Change: +$0.600 (+2%) info
Market Cap: $1.396B info
CDRE
Aug 05, 2026, 4:25 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $32.00
Real-time Price: $32.60 info
Change: +$0.600 (+2%) info
Market Cap: $1.396B info